影响胃癌腹腔脱落癌细胞阳性率的临床病理因素分析△

doi:10.3969/j.issn.1002-3070.2011.01.011

Abstract

Abstract:

Objective The aim was to investigate the relationship between the positive rate of exfoliative cancer cells of gastric cancer and clinicopathological factors.Methods We reviewed the records of 100 patients diagnosed with gastric carcinoma who were resected surgically.In order to test the positive rate of peritoneal free cancer cells,peritoneal washes(500mL)were obtained after laparotomy.Then we investigated the relationship between positive rate of peritoneal free cancer cells of gastric cancer and clinicopathological features.Results Free cancer cells of peritoneal washes were in 20 patients,the positive rate was 20%.Univariate analysis showed that age,tumor size,depth on invasion and histology were risk factors for the positive rate of peritoneal free cancer cells.Multivariate analysis showed depth on invasion,histology were independent factors for the positive rate of peritoneal free cancer cells.Conclusion Peritoneal free cells is the important factor of developing peritoneal metastasis,and the clinicopathological factors affect the positive rate of peritoneal free cancer cells of gastric cancer patients.

Key words: Gastric cancer, Peritoneal free cancer cell, Clinicopathological factor

CLC Number:

R735.2

ZHAO Shupeng,XUE Yingwei. The relationship between exfoliative cancer cells in peritoneal cavity of patients with gastric cancer and clinicopathological factors[J]. PRACTICAL ONCOLOGY JOURNAL, 2011, 25(1): 36-39.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.3969/j.issn.1002-3070.2011.01.011

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2011/V25/I1/36

[1]	LI Yun, SHI Pinghui. Analysis of gastroscopic screening and follow-up results among high-risk populations for gastric cancer in Gejiu City,Yunnan Province [J]. Journal of Practical Oncology, 2025, 39(5): 405-411.
[2]	DAI Fengxue, WANG Zhenfei. Research progress on the potential role and mechanism of hydrogen sulfide in the treatment of gastric cancer [J]. Journal of Practical Oncology, 2025, 39(4): 330-337.
[3]	CHEN Lijuan, MA Xinxin, GAO Guangqiang, TIAN Hong, LIU Jiaren. Research on the mechanism of dihydroactiniolide in inhibiting the proliferation of gastric cancer cells [J]. Journal of Practical Oncology, 2025, 39(2): 91-98.
[4]	MA Ming, WANG Wanying, RUAN Yuli, LIU Chao, ZHANG Yanqiao, MA Zhigang. The values of systemic inflammatory immune nutritional score in predicting the prognosis of immunotherapy for advanced gastric cancer [J]. Journal of Practical Oncology, 2025, 39(1): 39-48.
[5]	KONG Hongqian, DONG Juan, WEN Hongmei, SHAO Ying, CHENG Huirong, YU Qiuli. Analysis of gastric cancer incidence and mortality in cancer registration areas of Yunnan province in 2020 and the trends from 2012 to 2020 [J]. Journal of Practical Oncology, 2024, 38(6): 372-376.
[6]	LIAO Jun, LI Chunfeng, XUE Yingwei, ZU Hongliang. Research progress of lactate dehydrogenase in the diagnosis and treatment of gastric cancer [J]. Journal of Practical Oncology, 2024, 38(3): 200-206.
[7]	YANG Peng, LUO Jinmei, LUO Ping, XIE Xiaobo. An immune score model based on immune cell infiltration predicts the effects of immunotherapy and prognosis of early gastric cancer [J]. Journal of Practical Oncology, 2024, 38(2): 121-130.
[8]	GAO Chaofeng, ZHAO Zekun, WEI Fengxian, SUN Yuan, ZHOU Zhiming, XU Xiaodong. Research progress on perioperative nutritional management for gastric cancer [J]. Journal of Practical Oncology, 2023, 37(6): 519-523.
[9]	FU Xinya, HU Lingdan, ZHANG Zhijian, MA Xiumei. HPA promotes the invasion and metastasis of human gastric cancer cells by up-regulating MCP1/CCR2 [J]. Journal of Practical Oncology, 2023, 37(4): 329-336.
[10]	LI Juan, LIU Jiaren. The current research status and progress of immunotherapy for gastric cancer [J]. Journal of Practical Oncology, 2023, 37(4): 372-376.
[11]	MING Cheng, WU Yun. Research progress of Wnt/β-catenin signaling pathway and its inhibitors in gastric cancer [J]. Journal of Practical Oncology, 2023, 37(2): 190-194.
[12]	YANG Ju, LIU Qin, LIU Baorui, WEI Jia. Gastric cancer-associated cancer-testis antigen screening and immune infiltration analysis [J]. Journal of Practical Oncology, 2022, 36(6): 495-501.
[13]	XU Wei, LIU Haipeng, WANG Wenjie, WANG Zhou, LI Yuanyuan, SHEN Yimin, CHEN Xiao. Research progress on the causes and prevention measures of cholecystolithiasis after gastric cancer surgery [J]. Journal of Practical Oncology, 2022, 36(6): 561-565.
[14]	ZHAO Yaru, WU Yun. Research status of common biomarkers and corresponding targeted therapy for gastric cancer [J]. Journal of Practical Oncology, 2022, 36(5): 483-488.
[15]	ZHI Lianghui, LIU Wei, LI Wei, ZHEN Sihu, JIAO Xilin. Mechanism of lncRNA-ATB mediated epithelial mesenchymal transition in the progression of gastric cancer [J]. Journal of Practical Oncology, 2022, 36(3): 208-213.

The relationship between exfoliative cancer cells in peritoneal cavity of patients with gastric cancer and clinicopathological factors

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments